Skip to main content

Lipopolysaccharide (LPS)-related damage by H. pylori

  • Chapter
Helicobacter pylori

Abstract

The outer membrane of the cell wall of Gram-negative bacteria is a protective layer that controls the entry of many large molecules and protects the cell from potentially damaging agents. For those bacteria that come in contact with animals an important component of the Gram-negative outer membrane is lipopolysaccharide (LPS), a complex molecule not found elsewhere in nature. LPS, also termed endotoxin, represents the main surface antigen (O-antigen) for Gram-negative bacteria. The term endotoxin was coined by Pfeiffer in 1982, when he noted that certain toxic material was not excreted from living bacteria, as an exotoxin, but rather was released when the bacteria underwent lysis1. LPS is firmly bound to the bacterial cell and is composed of three main domains2 (Fig. 1). An outer polysaccharide chain, called the O-specific chain, contributes to the antigenicity and serospecificity of the molecule and is composed of repeating units that may contain up to seven different sugars. This O-specific chain is thus a polymer of identical repeating units, and is of large size since it can be up to 50 repeating units in length. The second component of the molecule is a short series of core sugars (approximately 10–15) while the innermost lipid component, termed lipid A, anchors LPS in the outer leaflet of the membrane. The fatty acids in lipid A vary with the microbial species, and endow hydrophobicity to the molecules. Thus LPS is an essential structure of all Gram-negative bacteria whether their natural habitat is salt lakes, ocean sediments, root nodules or the human gut. LPS is not a specific component to bacterial pathogens, rather it is a universal component of these organisms, be they friend or foe.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Rietschel ET, Brade H. Bacterial endotoxins. Sci Am. 1992; 267: 54–61.

    Article  PubMed  CAS  Google Scholar 

  2. Rietschel ET, Brade L, Holst O et al. Molecular structure of bacterial endotoxin in relation to bioactivity. In: Nowotny A, Spitzer JJ, Ziegler EJ, editors. Cellular and molecular aspects of endotoxin reactions. Amsterdam: Elsevier; 1990: 15–32.

    Google Scholar 

  3. Bocci V. The neglected organ: bacterial flora has a crucial immunostimulatory role. Prospect Biol Med. 1992; 35: 249–58.

    Google Scholar 

  4. Perez Perez GI, Blaser MJ. Conservation and diversity of Campylobacter pyloridis major antigens. Infect Immun 1987; 55: 1256–63.

    Google Scholar 

  5. Cohen PS, Arruda JC, Williams TJ, Laux DC. Adhesion of a human faecal Escherichia coli strain to mouse colonic mucus. Infect Immun. 1985; 48: 139–45.

    PubMed  CAS  Google Scholar 

  6. Myhal ML, Cohen PS, Laux DC. Altered colonising ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli. J Gen Microbiol. 1993; 129: 1549–58.

    Google Scholar 

  7. Moran AP, Helander IM, Kosunen TU. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol. 1992; 174: 1370–7.

    PubMed  CAS  Google Scholar 

  8. Moran AP, Walsh EJ. Expression and electrophoretic characterisation of smooth-form lipopolysaccharides of Helicobacter pylori. Acta Gastroenterol Belg. 1993; 56 (S): 97.

    Google Scholar 

  9. Mattsby-Baltzer I, Mielniczuk Z, Larsson L, Lindgren K, Goodwin S. Lipid-A in Helicobacter pylori. Infect Immun. 1992; 60: 4383–7.

    PubMed  CAS  Google Scholar 

  10. Weintraub A, Zahringer U, Wollenweber HW, Seydel U, Rietschel ET. Structural characterisation of the lipid A component of Bacteroides fragilis strain NCTC 9343 lipopolysaccharide. Eur J Biochem. 1989; 183: 425–31.

    Article  PubMed  CAS  Google Scholar 

  11. Hazen SL, Lee A, Brady L, Hennessy W. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaptation to an environment of mucus as important factors in colonization of the gastric epithelium. J Infect Dis. 1986; 153: 658–63.

    Article  Google Scholar 

  12. Steer HW. The gastro-duodenal epithelium in peptic ulceration. J Pathol. 1985; 146: 355–62.

    Article  PubMed  CAS  Google Scholar 

  13. Thomsen LL, Gavin JB, Tasman Jones C. Relation of Helicobacter pylori to the human gastric mucosa in chronic gastritis of the antrum. Gut. 1990; 31: 1230–6.

    Article  PubMed  CAS  Google Scholar 

  14. Mai UE, Perez Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharideindependent mechanism. J Clin Invest. 1991; 87: 894–900.

    Article  PubMed  CAS  Google Scholar 

  15. Blaser MJ. Hypothesis on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology. 1992; 102: 720–7.

    PubMed  CAS  Google Scholar 

  16. Trust TJ, Doig P, Emody L, Kienle Z, Wadstrom T, O’Toole P. High affinity binding of the basement membrane proteins collagen type IV and laminin to the gastric pathogen Helicobacter pylori. Infect Immun. 1991; 59: 4398–404.

    PubMed  CAS  Google Scholar 

  17. Slomiany BL, Piotrowski J, Sengupta S, Slomiany A. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide. Biochem Biophys Res Commun. 1991; 175: 963–70.

    Article  PubMed  CAS  Google Scholar 

  18. Slomiany BL, Piotrowski J, Rajiah G, Slomiany A. Inhibition of gastric mucosa laminin receptor by Helicobacter pylori lipopolysaccharide: effect of nitecapone. Gen Pharmacol. 1991; 22: 1063–9.

    Article  PubMed  CAS  Google Scholar 

  19. Piotrowski J, Yamaki K, Slomiany A, Slomiany BL. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori: effect of sucralfate. Am J Gastroenterol. 1991; 86: 1756–60.

    PubMed  CAS  Google Scholar 

  20. Piotrowski J, Morita M, Slomiany A, Slomiany BL. Inhibition of gastric mucosal laminin receptor by Helicobacter pylori lipopolysaccharide - effect of ebrotidine. Biochem Int. 1992; 27: 131–8.

    PubMed  CAS  Google Scholar 

  21. Slomiany A, Piotrowski J, Yotsumoto F, Czajkowski A, Slomiany BL. H. pylori lipopolysaccharide inhibition of gastric mucosal laminin receptor: effect of sulglycotide. Acta Gastroenterol Belg. 1993; 65 (suppl.): 120.

    Google Scholar 

  22. Valkonen KH, Ringner M, Ljungh A, Wadstrom T. High-affinity binding of laminin by Helicobacter pylori - evidence for a lectin-like interaction. FEMS Immunol Med Microbiol. 1993; 7: 29–37.

    Article  PubMed  CAS  Google Scholar 

  23. Moran AP, Kuusela P, Kosunen TU. Interaction of Helicobacter pylori with extracellular matrix proteins. J Appl Bacteriol. 1993; 75: 184–9.

    Article  CAS  Google Scholar 

  24. Glass GBJ, Slomiany BL. Derangements of biosynthesis, production and secretion of mucus in gastrointestinal injury and disease. In: Elstein M, Parke DV, editors. Mucus in health and disease. New York: Plenum Press; 1977: 311–47.

    Chapter  Google Scholar 

  25. Murakami S, Mori Y. Changes in the incorporating activity of 35S-sulphate into gastric sulfated glycoproteins in the rat with erosions by restraint and water immersion stress. Jpn J Pharmacol. 1984; 35: 279–86.

    Article  PubMed  CAS  Google Scholar 

  26. Azumi Y, Ohara S, Ishihara K, Okabe H, Hotta K. Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. Gut. 1980; 21: 533–6.

    Article  Google Scholar 

  27. Younan F, Pearson J, Allen A, Venables C. Changes in the structure of the mucous gel on the mucosal surface of the stomach in association with peptic ulcer disease. Gastroenterology. 1982; 82: 827–31.

    PubMed  CAS  Google Scholar 

  28. Slomiany BL, Liau YH, Lopez RA, Piotrowski J, Czajkowski A, Slomiany A. Effect of Helicobacter pylori lipopolysaccharide on the synthesis of sulfated gastric mucin. Biochem Int. 1992; 27: 687–97.

    PubMed  CAS  Google Scholar 

  29. Pearson JP, Ward R, Allen A, Roberts NB, Taylor WH. Mucus degradation by pepsin: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Gut. 1986; 27: 243–8.

    Article  PubMed  CAS  Google Scholar 

  30. Venables CW. Mucus, pepsin, and peptic ulcer. Gut. 1986; 27: 233–8.

    Article  PubMed  CAS  Google Scholar 

  31. Waldrum HL, Burhol PG, Straume BK. Serum group I pepsinogens and gastrin in relation to gastric H+ and pepsin outputs before and after subcutaneous injection of pentagastrin. Scand J Gastroenterol. 1978; 13: 943–6.

    Article  Google Scholar 

  32. Sumii K, Inbe A, Uemura N et al. Increased serum pepsinogen 1 and recurrence of duodenal ulcer. Scand J Gastroenterol. 1989; 24: 1200–4.

    Article  PubMed  CAS  Google Scholar 

  33. Samloff IM, Stemmermann GN, Heilbrun LK, Nomura A. Elevated serum pepsinogen I and II levels differ as risk factors for duodenal ulcer and gastric ulcer. Gastroenterology. 1986; 90: 570–6.

    PubMed  CAS  Google Scholar 

  34. Young GO, Stemmet N, Lastovica A et al. Helicobacter pylori lipopolysaccharide stimulates mucosal pepsinogen secretion. Aliment Pharmacol Ther. 1992; 6: 169–77.

    Article  PubMed  CAS  Google Scholar 

  35. Cave TR, Cave DR. Helicobacter pylori stimulates pepsin secretion from isolated rabbit gastric glands. Scand J Gastroenterol. 1991; 26: 9–14.

    Article  CAS  Google Scholar 

  36. Muotiala A, Helander IM. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun 1992; 60: 1714–16.

    PubMed  CAS  Google Scholar 

  37. Birkholz S, Knipp U, Nietzki C, Adamek RJ, Opferkuch W. Immunological activity of lipopolysaccharide of Helicobacter pylori on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria. FEMS Immunol Med Microbiol. 1993; 6: 317–24.

    Article  PubMed  CAS  Google Scholar 

  38. Kauffman F. The bacteriology of the Enterobacteriaeceae. Copenhagen: Munksgaard; 1966: 55–309.

    Google Scholar 

  39. Penner JL, Hennessy JN. Possible haemagglutination technique for serotyping Campylobacter fetus subs. jejuni on the basis of heat-stable antigens. J Clin Microbiol. 1983; 12: 732–7.

    Google Scholar 

  40. Mills SD, Kurjanczyk LA, Penner JL. Antigenicity of Helicobacter pylori lipopolysaccharides. J Clin Microbiol. 1992; 30: 3175–80.

    PubMed  CAS  Google Scholar 

  41. Crabtree JE, Plusa S, Farmery S, Peichl P, Lindley IJD. Cytokine regulation of interleukin-8 secretion by gastric epithelial cell lines. Acta Gastroenterol Belg. 1993; 56 (S): 52.

    Google Scholar 

  42. Crabtree JE, Farmery S, Lindley IJD, Peichl P. Cytotoxic strains of Helicobacter pylori induce IL-8 production by gastric epithelial cells. Acta Gastroenterol Belg. 1993; 56 (S): 48.

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Lee, A., Moran, A.P. (1994). Lipopolysaccharide (LPS)-related damage by H. pylori . In: Hunt, R.H., Tytgat, G.N.J. (eds) Helicobacter pylori. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1418-9_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1418-9_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4620-6

  • Online ISBN: 978-94-011-1418-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics